Skip to main content

F-star Therapeutics, Inc.

FSTXDelisted Mar 9, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001566373

F-star Therapeutics, Inc. was delisted on Mar 9, 2023; its insiders filed their last Form 4 on Mar 9, 2023; 59 institutions reported holding it in 13F filings for Q4 2022, worth $57.8M in total; Fairfax Financial was the only superinvestor holding it.

Superinvestors holding FSTX, Q4 2022

1 superinvestor reports holding F-star Therapeutics, Inc. on Form 13F, worth $311.7K in total. Weight is F-star Therapeutics, Inc.'s share of each 13F portfolio; actions compare shares with Q3 2022.

See all superinvestors
Superinvestors holding FSTX in Q4 2022
Superinvestor% of portfolioSharesValuevs. previous quarter
Fairfax FinancialPrem Watsa<0.1%49,399$311.7KAdded+102.5%

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of FSTX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q4 2022

    1 superinvestor holding at quarter end

    Added
    Fairfax Financial (+102.5%)
  2. Q3 2022

    1 superinvestor holding at quarter end

    New
    Fairfax Financial